Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 1201-1250 of 1653 result(s).
CYDY CytoDyn Inc
08/31/2020 10:31:51 AM
I remain optimistic that the worm w (1)
CYDY CytoDyn Inc
08/31/2020 10:23:52 AM
Like Bill Murray, we have had plent
CYDY CytoDyn Inc
08/31/2020 10:01:46 AM
Shelly, I’m not the market expert
CYDY CytoDyn Inc
08/30/2020 7:09:18 PM
CDiddy, I agree 100%. Excess death (1)
CYDY CytoDyn Inc
08/30/2020 6:43:49 PM
CDiddy, Excess death measurement is (4)
CYDY CytoDyn Inc
08/29/2020 8:09:31 PM
SAF, Thanks for the heads up. My re (4)
CYDY CytoDyn Inc
08/29/2020 4:09:14 PM
Frip, That presupposes a final disp (2)
CYDY CytoDyn Inc
08/29/2020 2:45:09 PM
Dr Z, Nothing to do with uplist and (1)
CYDY CytoDyn Inc
08/29/2020 2:07:25 PM
Frip, Your response does not answer
CYDY CytoDyn Inc
08/29/2020 7:08:08 AM
Just saw the news that Chadwick Bos (2)
CYDY CytoDyn Inc
08/29/2020 6:56:34 AM
Frip99, The criteria for NASDAQ upl (2)
CYDY CytoDyn Inc
08/28/2020 6:21:37 AM
Chuckles, I believe you are exactly
CYDY CytoDyn Inc
08/27/2020 7:28:06 PM
More evidence that ohm20 is way ahe (6)
CYDY CytoDyn Inc
08/27/2020 7:16:12 PM
Misiu143, I have been impressed by (7)
CYDY CytoDyn Inc
08/27/2020 6:57:55 PM
Invisioner, The manner in which CCR (6)
CYDY CytoDyn Inc
08/27/2020 6:36:10 PM
Misiu143, I hope that the delay in (1)
CYDY CytoDyn Inc
08/27/2020 5:37:05 PM
Thanks. I was not certain if my pos
CYDY CytoDyn Inc
08/27/2020 5:31:17 PM
Misiu, Thanks for watching. Four ni
CYDY CytoDyn Inc
08/27/2020 4:51:12 PM
nbmr1: I am reiterating what was sa
CYDY CytoDyn Inc
08/27/2020 4:41:13 PM
Ritz, I read that here or on the sh
CYDY CytoDyn Inc
08/27/2020 4:26:41 PM
Heads, Someone stated on the first
CYDY CytoDyn Inc
08/27/2020 3:52:55 PM
FKA, Thanks for the support of civi (2)
CYDY CytoDyn Inc
08/27/2020 3:25:20 PM
SAF, Thank you. I apologize for bei (2)
CYDY CytoDyn Inc
08/27/2020 3:15:28 PM
Latane, I apologize as I could cert
CYDY CytoDyn Inc
08/27/2020 3:09:36 PM
SAF, I have plenty of skin in the g (4)
CYDY CytoDyn Inc
08/27/2020 2:37:56 PM
Fortuno: You said "They’re taking (7)
CYDY CytoDyn Inc
08/27/2020 2:27:27 PM
Primary endpoint is mortally at 28
CYDY CytoDyn Inc
08/27/2020 2:23:53 PM
SAF: 1. A biotech does not need to (17)
CYDY CytoDyn Inc
08/27/2020 5:26:21 AM
Dr. Z The group surrounding Preside (3)
CYDY CytoDyn Inc
08/26/2020 8:15:14 PM
Ohm20, It is hard to see the forest
CYDY CytoDyn Inc
08/26/2020 8:10:39 PM
Vicr, I may have made an unsupporte (3)
CYDY CytoDyn Inc
08/26/2020 7:14:41 PM
More supporting evidence for RANTES (2)
CYDY CytoDyn Inc
08/26/2020 5:45:25 PM
Pourhassan: “ “We have not subm (1)
CYDY CytoDyn Inc
08/26/2020 5:14:59 PM
Thrifty, That was the most carefull (3)
CYDY CytoDyn Inc
08/26/2020 2:57:22 PM
Not PR worthy but absolutely worth
CYDY CytoDyn Inc
08/26/2020 2:53:44 PM
A new (at least to me), article on
CYDY CytoDyn Inc
08/26/2020 12:57:01 PM
Mtruong, Correct on statistical pow
CYDY CytoDyn Inc
08/26/2020 11:01:55 AM
Mrtuong34, There was not error in m
CYDY CytoDyn Inc
08/26/2020 10:51:31 AM
The standard of care is whatever th (3)
CYDY CytoDyn Inc
08/26/2020 10:36:12 AM
Zadie, I am extremely sorry for you
CYDY CytoDyn Inc
08/26/2020 10:31:28 AM
I don't intend to be difficult, but (4)
CYDY CytoDyn Inc
08/26/2020 10:19:50 AM
Misiu143, Remember that placebo in (6)
CYDY CytoDyn Inc
08/26/2020 10:06:33 AM
I'll agree to disagree. We had many (6)
CYDY CytoDyn Inc
08/26/2020 9:19:01 AM
Misiu143, I understand completely t
CYDY CytoDyn Inc
08/26/2020 8:23:46 AM
Double blinded, placebo controlled (3)
CYDY CytoDyn Inc
08/26/2020 6:57:57 AM
Cytodyn conducts the interim analys (1)
CYDY CytoDyn Inc
08/25/2020 7:50:59 PM
The Patterson preprint has been on (1)
CYDY CytoDyn Inc
08/25/2020 7:46:11 PM
Ohm20, I am glad your friend has re (11)
CYDY CytoDyn Inc
08/25/2020 6:14:19 PM
Annual economic impact of stroke in (1)
CYDY CytoDyn Inc
08/25/2020 5:52:45 PM
More evidence that ohm20 is way ahe (5)
Go to page:
  • << First
  • < Previous
  • 24
  • 25
  • Next >

Recent Articles

  • Centene Corporation Class Action Lawsuit: What Investors Need to Know
  • Investors Investigate LifeMD, Inc. After Recent Earnings Drop
  • Exciting Travel Deals Now Available in Germany for Adventurers
  • Lockheed Martin Shareholders Should Act Now Amid Lawsuit Risk
  • Sarepta Therapeutics: Join the Class Action for Compensation
  • Petco Health and Wellness Faces Class Action Deadline Soon
  • Dogecoin Investors Showcase Rugged Optimism Amid Market Decline
  • Tim Cook's Gift to Trump Reflects Apple's $100 Billion Pledge
  • AT&T Inc. Reveals $177 Million Settlement for Data Breaches
  • Overcoming the Challenges of Connected TV Advertising Today
  • The Impact of AI on Financial Markets: A Cautionary Tale
  • Kevin O'Leary's Innovative Executive Hiring Model Explained
  • New Talks Aim for Lasting Peace as Tensions Escalate
  • Innovative AI Platform from GridStrat Enhances Market Strategies
  • New Chip Export Dynamics Shaping Global Semiconductor Market
  • Investors Urged to Act as Hims & Hers Health Faces Legal Scrutiny
  • Petco Investors Examined for Claims Amid Stock Decline
  • Transforming Work: AI Replaces Soul-Crushing Jobs Amid Growth
  • Investigation Launched on Investor Claims against Centene Corp
  • John Paulson Expands Portfolio with Alphabet and Gold Miner
  • ExpandCommunication Revolutionizes Public Relations with AI
  • Important Investor Update on Sarepta Therapeutics' Safety Claims
  • Rillet Secures $70M Investment to Innovate AI in Accounting
  • Coatue Management's Strategic Bet on AI and Cloud Growth
  • Celebrate Nature With the New Luna Moth Stamp Release
  • Lineage, Inc. Investors: Important Class Action Deadline Ahead
  • Legal Action Update: Investors Target Novo and Others
  • Jim Cramer Encourages Investors to Stay Confident Amid Market Swings
  • Centene Corporation Securities Class Action: Key Details for Investors
  • Explore the Hidden Industries Booming Under the Radar
  • Understanding Relevant Class Actions Against Major Firms
  • Replimune Group, Inc. Investors Should Take Action Now
  • Greenlight Capital's Strategic Moves: Insights into Q2 2025
  • Class Action Alert: Reddit Investors Must Act Before Deadline
  • Understanding the Legal Activity Surrounding Hims Inc. Shares
  • Sarepta Therapeutics Faces Lawsuit: Take Action Before Deadline
  • Alto Neuroscience Shareholder Class Action: Important Updates
  • Datumo's $15.5 Million Fund Boosts AI Evaluation Tools
  • IRS Clarifies No New Stimulus Checks Will Be Issued This Year
  • CTO Realty Growth Investors: Act Now for Class Action Rights
  • Danielle Panabaker's Crossover Experience: Pay Issues Revealed
  • New Forever Stamp Celebrates Legacy of Former President Carter
  • XPPen Marks 20 Years of Innovation and Creativity in Art
  • Investigation Launched for Investors of GSK plc Amid Concerns
  • Unraveling Investor Concerns Involving Confluent, Inc. Stock
  • Investigation into Neogen Corporation Raises Concerns for Investors
  • Class Action Filed Against Alto Neuroscience Over IPO Misrepresentation
  • Class Action Lawsuit Announced Against Hims & Hers Health, Inc.
  • Understanding the Legal Landscape for PetMed Investors
  • Class Action Filed Against Flywire Corporation: A Legal Overview
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site